Locke DEC - Search Results

1

Neuropsychological decline up to 20 years before incident mild cognitive impairment.

Caselli RJ, Langlais BT, Dueck AC, Chen Y, Su Y, Locke DEC, Woodruff BK, Reiman EM. Caselli RJ, et al. Among authors: locke dec. Alzheimers Dement. 2020 Mar;16(3):512-523. doi: 10.1016/j.jalz.2019.09.085. Epub 2020 Jan 6. Alzheimers Dement. 2020. PMID: 31787561 Free PMC article.

2

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D. Caselli RJ, et al. Arch Neurol. 2007 Sep;64(9):1306-11. doi: 10.1001/archneur.64.9.1306. Arch Neurol. 2007. PMID: 17846270

3

Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaire.

Locke DE, Dassel KB, Hall G, Baxter LC, Woodruff BK, Hoffman Snyder C, Miller BL, Caselli RJ. Locke DE, et al. Dement Geriatr Cogn Disord. 2009;27(3):260-72. doi: 10.1159/000203890. Epub 2009 Feb 25. Dement Geriatr Cogn Disord. 2009. PMID: 19246911 Free PMC article.

4

Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM. Caselli RJ, et al. N Engl J Med. 2009 Jul 16;361(3):255-63. doi: 10.1056/NEJMoa0809437. N Engl J Med. 2009. PMID: 19605830 Free PMC article.

5

Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes.

Caselli RJ, Dueck AC, Locke DE, Sabbagh MN, Ahern GL, Rapcsak SZ, Baxter LC, Yaari R, Woodruff BK, Hoffman-Snyder C, Rademakers R, Findley S, Reiman EM. Caselli RJ, et al. Neurology. 2011 Mar 22;76(12):1078-84. doi: 10.1212/WNL.0b013e318211c3ae. Epub 2011 Feb 16. Neurology. 2011. PMID: 21325652 Free PMC article.

6

Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers.

Caselli RJ, Dueck AC, Locke DE, Hoffman-Snyder CR, Woodruff BK, Rapcsak SZ, Reiman EM. Caselli RJ, et al. Neurology. 2011 Apr 19;76(16):1383-8. doi: 10.1212/WNL.0b013e3182167147. Neurology. 2011. PMID: 21502596 Free PMC article.

7

Anxiety affects cognition differently in healthy apolipoprotein E ε4 homozygotes and non-carriers.

Stonnington CM, Locke DE, Dueck AC, Caselli RJ. Stonnington CM, et al. J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):294-9. doi: 10.1176/jnp.23.3.jnp294. J Neuropsychiatry Clin Neurosci. 2011. PMID: 21948890

8

Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive aging.

Locke DE, Stonnington CM, Thomas ML, Caselli RJ. Locke DE, et al. J Clin Exp Neuropsychol. 2011 Oct;33(8):937-43. doi: 10.1080/13803395.2011.578571. Epub 2011 Jun 27. J Clin Exp Neuropsychol. 2011. PMID: 21950515 Free PMC article.

9

Is donepezil effective for multiple sclerosis-related cognitive dysfunction? A critically appraised topic.

O'Carroll CB, Woodruff BK, Locke DE, Hoffman-Snyder CR, Wellik KE, Thaera GM, Demaerschalk BM, Wingerchuk DM. O'Carroll CB, et al. Neurologist. 2012 Jan;18(1):51-4. doi: 10.1097/NRL.0b013e31823fa3ba. Neurologist. 2012. PMID: 22217618

10

The neuropsychology of normal aging and preclinical Alzheimer's disease.

Caselli RJ, Locke DE, Dueck AC, Knopman DS, Woodruff BK, Hoffman-Snyder C, Rademakers R, Fleisher AS, Reiman EM. Caselli RJ, et al. Alzheimers Dement. 2014 Jan;10(1):84-92. doi: 10.1016/j.jalz.2013.01.004. Epub 2013 Mar 26. Alzheimers Dement. 2014. PMID: 23541188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page